Vault-13

AJU IB Investment Co., Ltd.

Seoul, M5 · CIK 1710065 · 13F filing filed 2022-05-12

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$64.8m reported value -9.8% vs Q4 2021
7positions
100.0%in top 10
1 new 0 added 0 reduced 0 sold out vs Q4 2021

Holdings, Q1 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ARCELLX INC COMMON STOCK ACLX ACLX 1,380,890 $19.4m29.89% 29.89% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 1.4m
2 KYMERA THERAPEUTICS INC COM KYMR KYMR 457,059 $19.3m29.87% 29.87% UnchangedShares held: Q2 2021 639.1k, Q3 2021 639.1k, Q4 2021 457.1k, Q1 2022 457.1k
3 SEER INC COM CL A SEER SEER 816,375 $12.4m19.21% 19.21% UnchangedShares held: Q2 2021 816.4k, Q3 2021 816.4k, Q4 2021 816.4k, Q1 2022 816.4k
4 RALLYBIO CORP COM COM 754,678 $5.3m8.13% 8.13% UnchangedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 754.7k, Q1 2022 754.7k
5 XILIO THERAPEUTICS INC COM COM 667,742 $4.7m7.29% 7.29% UnchangedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 667.7k, Q1 2022 667.7k
6 RAPT THERAPEUTICS INC COM COM 99,503 $2.2m3.38% 3.38% UnchangedShares held: Q2 2021 99.5k, Q3 2021 99.5k, Q4 2021 99.5k, Q1 2022 99.5k
7 SUTRO BIOPHARMA INC COM COM 175,000 $1.4m2.22% 2.22% UnchangedShares held: Q2 2021 175.0k, Q3 2021 175.0k, Q4 2021 175.0k, Q1 2022 175.0k